BeiGene · 6 hours ago
Summer Internship: Medical Affairs Intern (Remote)
United States
Internship
Remote
Intern
$27/hr - $35/hrBeOne Medicines is a rapidly growing company focused on fighting cancer, and they are seeking a Medical Affairs Intern. The intern will collaborate on various ongoing projects within Medical Affairs, gaining hands-on experience while supporting medical strategies, insight generation, and scientific communications.
BiotechnologyHealth CareLife ScienceMedical
Responsibilities
Assisting the Medical Affairs team in research activities, literature reviews, and data analyses
Assisting in the development of medical education materials, presentations, publications, scientific communication/medical information resources for healthcare professionals and/or patients
Supporting the implementation of Digital Communication Plan
Organizing and facilitating congress planning, Advisory Board meetings, and symposia
Organizing and managing Medical Affairs workstreams, meetings, agendas, and minutes
Tracking project progress and deliverables to drive results, communicating changes and progress, and completing assigned projects on time
Qualification
Required
Students enrolled in Undergraduate, Master's, or Doctorate programs in the USA with a focus in science and/or health care discipline (examples: BS, MPH, MS, MD, PharmD, PhD programs)
Proficient in MS Office: Outlook, Word, Excel, PowerPoint, OneNote, Teams (and Zoom)
Interest in pursuing a career in Medical Affairs and/or the Biotech industry
Self-motivated, ability to manage multiple projects and work in a fast-paced, dynamic, multi-cultural environment
Strong organizational, communication (verbal and written), and interpersonal skills
Embrace BeOne Medicines' core values and competencies
Benefits
Medical
Dental
Vision
401(k)
FSA/HSA
Life Insurance
Paid Time Off
Wellness
Company
BeiGene
BeiGene is a global oncology company.
Founded in 2010
0-1 employees
Funding
Current Stage
Public CompanyTotal Funding
$6.79BKey Investors
Hillhouse InvestmentAmgen
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M
Leadership Team
Dirk Weber
Executive Director Medical Affairs (Europe)
Lai Wang
Global Head of Research and Development
Recent News
2026-01-07
Company data provided by crunchbase